RSS feed

Publications by Jostein Dahle

39 publications found

Original articles

Mothersill C, Antonelli F, Dahle J, Dini V, Hegyesi H, Iliakis G, Kämäräinen K, Launonen V, Lumniczky K, Lyng F, Safrany G, Salomaa S, Schilling-Tóth B, Tabocchini A, Kadhim MA (2012)
A laboratory inter-comparison of the importance of serum serotonin levels in the measurement of a range of radiation-induced bystander effects: overview of study and results presentation
Int J Radiat Biol, 88 (10), 763-9
DOI 10.3109/09553002.2012.715795, PubMed 22891994

Kalanxhi E, Dahle J (2012)
The role of serotonin and p53 status in the radiation-induced bystander effect
Int J Radiat Biol, 88 (10), 773-6
DOI 10.3109/09553002.2012.711919, PubMed 22803606

Abbas N, Bruland ØS, Brevik EM, Dahle J (2012)
Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts
Nucl Med Commun, 33 (8), 838-47
DOI 10.1097/MNM.0b013e328354df7c, PubMed 22643311

Kalanxhi E, Dahle J (2012)
Transcriptional responses in irradiated and bystander fibroblasts after low dose α-particle radiation
Int J Radiat Biol, 88 (10), 713-9
DOI 10.3109/09553002.2012.704657, PubMed 22765265

Heyerdahl H, Abbas N, Brevik EM, Mollatt C, Dahle J (2012)
Fractionated therapy of HER2-expressing breast and ovarian cancer xenografts in mice with targeted alpha emitting 227Th-DOTA-p-benzyl-trastuzumab
PLoS One, 7 (8), e42345
DOI 10.1371/journal.pone.0042345, PubMed 22879947

Kalanxhi E, Dahle J (2011)
Genome-wide microarray analysis of human fibroblasts in response to γ radiation and the radiation-induced bystander effect
Radiat Res, 177 (1), 35-43
DOI 10.1667/rr2694.1, PubMed 22034846

Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
Curr Radiopharm, 4 (4), 321-8
DOI 10.2174/1874471011104040321, PubMed 22202154

Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J (2011)
Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
EJNMMI Res, 1 (1), 18
DOI 10.1186/2191-219X-1-18, PubMed 22214432

Dahle J, Kalanxhi E, Tisnek N (2011)
Dosimetry of a 238Pu-based alpha-particle irradiator and its biological application in a study of the bystander effect
Anticancer Res, 31 (6), 2113-20
PubMed 21737630

Heyerdahl H, Krogh C, Borrebæk J, Larsen Å, Dahle J (2011)
Treatment of HER2-expressing breast cancer and ovarian cancer cells with alpha particle-emitting 227Th-trastuzumab
Int J Radiat Oncol Biol Phys, 79 (2), 563-70
DOI 10.1016/j.ijrobp.2010.08.038, PubMed 21195878

Dahle J, Jonasdottir TJ, Heyerdahl H, Nesland JM, Borrebaek J, Hjelmerud AK, Larsen RH (2010)
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximab
Eur J Nucl Med Mol Imaging, 37 (1), 93-102
DOI 10.1007/s00259-009-1197-7, PubMed 19593562

Tisnek N, Kalanxhi E, Serkland CW, Iversen J, Belyakov OV, Dahle J (2009)
A (238)Pu irradiator for exposure of cultured cells with alpha-radiation: construction, calibration and dosimetry
Appl Radiat Isot, 67 (11), 1998-2002
DOI 10.1016/j.apradiso.2009.08.003, PubMed 19716308

Dahle J, Krogh C, Melhus KB, Borrebaek J, Larsen RH, Kvinnsland Y (2009)
In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab
Int J Radiat Oncol Biol Phys, 75 (3), 886-95
DOI 10.1016/j.ijrobp.2009.04.062, PubMed 19679402

Dahle J, Bruland OS, Larsen RH (2008)
Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation
Int J Radiat Oncol Biol Phys, 72 (1), 186-92
DOI 10.1016/j.ijrobp.2008.05.029, PubMed 18722269

Dahle J, Brunborg G, Svendsrud DH, Stokke T, Kvam E (2008)
Overexpression of human OGG1 in mammalian cells decreases ultraviolet A induced mutagenesis
Cancer Lett, 267 (1), 18-25
DOI 10.1016/j.canlet.2008.03.002, PubMed 18406515

Dahle J, Larsen RH (2008)
Targeted Alpha-Particle Therapy with Th-227-Labeled Antibodies
Curr. Radiopharm., 1 (3), 209-214
DOI 10.2174/1874471010801030209

Dahle J, Krogh C, Melhus KB, Kaalhus O, Larsen RH, Stokke T (2007)
A one-step method for determining the maximum number of bound antibodies, and the affinity and association rate constants for antibody binding
Nucl Med Commun, 28 (9), 742-7
DOI 10.1097/MNM.0b013e3282e2a86b, PubMed 17667754

Melhus KB, Larsen RH, Stokke T, Kaalhus O, Selbo PK, Dahle J (2007)
Evaluation of the binding of radiolabeled rituximab to CD20-positive lymphoma cells: an in vitro feasibility study concerning low-dose-rate radioimmunotherapy with the alpha-emitter 227Th
Cancer Biother Radiopharm, 22 (4), 469-79
DOI 10.1089/cbr.2007.371, PubMed 17803441

Larsen RH, Borrebaek J, Dahle J, Melhus KB, Krogh C, Valan MH, Bruland OS (2007)
Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding ability
Cancer Biother Radiopharm, 22 (3), 431-7
DOI 10.1089/cbr.2006.321, PubMed 17651051

Dahle J, Borrebaek J, Jonasdottir TJ, Hjelmerud AK, Melhus KB, Bruland ØS, Press OW, Larsen RH (2007)
Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate
Blood, 110 (6), 2049-56
DOI 10.1182/blood-2007-01-066803, PubMed 17536011

Dahle J, Borrebaek J, Melhus KB, Bruland OS, Salberg G, Olsen DR, Larsen RH (2006)
Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy
Nucl Med Biol, 33 (2), 271-9
DOI 10.1016/j.nucmedbio.2005.12.004, PubMed 16546683

Dahle J, Kvam E, Stokke T (2005)
Bystander effects in UV-induced genomic instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet A and B radiation
J Carcinog, 4, 11
DOI 10.1186/1477-3163-4-11, PubMed 16091149

Kvam E, Dahle J (2005)
The pheomelanin precursor 5-S-cysteinyldopa protects melanocytes from membrane damage induced by ultraviolet A radiation
Cancer Lett, 221 (2), 131-4
DOI 10.1016/j.canlet.2004.08.025, PubMed 15808398

Dahle J, Kaalhus O, Stokke T, Kvam E (2005)
Bystander effects may modulate ultraviolet A and B radiation-induced delayed mutagenesis
Radiat Res, 163 (3), 289-95
DOI 10.1667/rr3305, PubMed 15733036

Dahle J, Noordhuis P, Stokke T, Svendsrud DH, Kvam E (2005)
Multiplex polymerase chain reaction analysis of UV-A- and UV-B-induced delayed and early mutations in V79 Chinese hamster cells
Photochem Photobiol, 81 (1), 114-9
DOI 10.1562/2004-05-19-RA-174, PubMed 15453821

Dahle J, Kakar M, Steen HB, Kaalhus O (2004)
Automated counting of mammalian cell colonies by means of a flat bed scanner and image processing
Cytometry A, 60 (2), 182-8
DOI 10.1002/cyto.a.20038, PubMed 15290719

Dahle J, Kvam E (2004)
Increased level of oxidative stress in genomically unstable cell clones
J Photochem Photobiol B, 74 (1), 23-8
DOI 10.1016/j.jphotobiol.2004.01.004, PubMed 15043843

Kvam E, Dahle J (2003)
Pigmented melanocytes are protected against ultraviolet-A-induced membrane damage
J Invest Dermatol, 121 (3), 564-9
DOI 10.1046/j.1523-1747.2003.12418.x, PubMed 12925216

Dahle J, Kvam E (2003)
Induction of delayed mutations and chromosomal instability in fibroblasts after UVA-, UVB-, and X-radiation
Cancer Res, 63 (7), 1464-9
PubMed 12670891

Dahle J, Angell-Petersen E, Steen HB, Moan J (2001)
Bystander effects in cell death induced by photodynamic treatment UVA radiation and inhibitors of ATP synthesis
Photochem Photobiol, 73 (4), 378-87
DOI 10.1562/0031-8655(2001)073<0378:beicdi>2.0.co;2, PubMed 11332033

Dahle J, Mikalsen SO, Rivedal E, Steen HB (2000)
Gap junctional intercellular communication is not a major mediator in the bystander effect in photodynamic treatment of MDCK II cells
Radiat Res, 154 (3), 331-41
DOI 10.1667/0033-7587(2000)154[0331:gjicin]2.0.co;2, PubMed 10956441

Dahle J, Bagdonas S, Kaalhus O, Olsen G, Steen HB, Moan J (2000)
The bystander effect in photodynamic inactivation of cells
Biochim Biophys Acta, 1475 (3), 273-80
DOI 10.1016/s0304-4165(00)00077-5, PubMed 10913826

Dahle J, Steen HB, Moan J (1999)
The mode of cell death induced by photodynamic treatment depends on cell density
Photochem Photobiol, 70 (3), 363-7
DOI 10.1562/0031-8655(1999)070<0363:TMOCDI>2.3.CO;2, PubMed 10483366

Bagdonas S, Dahle J, Kaalhus O, Moan J (1999)
Cooperative inactivation of cells in microcolonies treated with UVA radiation
Radiat Res, 152 (2), 174-9
DOI 10.2307/3580091, PubMed 10409327

Dahle J, Angel-Petersen E, Bagdonas S, Steen HB, Moan J (1999)
Cooperative effects of photosensitized cell killing
P SOC PHOTO-OPT INS, 3563, 120-124
DOI 10.1117/12.339127

Dahle J, Kaalhus O, Moan J, Steen HB (1997)
Cooperative effects of photodynamic treatment of cells in microcolonies
Proc Natl Acad Sci U S A, 94 (5), 1773-8
DOI 10.1073/pnas.94.5.1773, PubMed 9050854

Other articles

Kvam E, Dahle J (2004)
Melanin synthesis may sensitize melanocytes to oxidative DNA damage by ultraviolet A radiation and protect melanocytes from direct DNA damage by ultraviolet B radiation
Pigment Cell Res, 17 (5), 549-50
DOI 10.1111/j.1600-0749.2004.00168.x, PubMed 15357843

Book chapters

Bruland S, Dahle J, Olsen DR, Larsen RH (2008)
Targeted high-LET therapy of bone metastases
In Targeted radionuclide tumor therapy. Biological aspects (Stigbrand T, Carlsson J, Adams GP, eds.), Springer Verlag
PublikaID 25, ISBN 978-1-4020-8695-3

Theses

Dahle J (2000)
Cell-to-cell interactions in photosensitized inactivationof cells
In Series of dissertations submitted to the Faculty of Mathematics and Natural Sciences, University of Oslo, The Faculty, Oslo, no. 49, 1 b. (flere pag.)
BIBSYS 000480347